Macrotope

Founded with a mission to revolutionize immunology, Macrotope specializes in protein antigen design and production to support therapeutic antibody and vaccine discovery. The company leverages its extensive IP portfolio and decades of experience in antigen production, protein folding, and biochemistry to offer cutting-edge solutions. Macrotope's core product, the MacroAntigen™ Platform, is designed to enhance the immune response, making it a crucial partner for organizations focused on developing innovative vaccines and antibodies.

Macrotope's team comprises leading experts in immunology and biochemistry, contributing to its reputation as a pioneer in antigen-centric approaches. The company has garnered attention from notable investors in the biotech sector, further validating its impact and potential. Key achievements include the successful integration of its MacroAntigen Vaccine (MAV™) technology into various therapeutic pipelines, significantly advancing the field of antibody discovery. Overall, Macrotope has made substantial contributions to immunological research and therapeutic development, positioning itself as a vital player in the biotech industry.